Raymond James Financial’s Shattuck Labs STTK Stock Holding History

Raymond James Financial’s Portfolio STTK Stock Details STTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-250	Closed	-$198	–	6561
2025 Q2	$198	Buy	+250	New	+$242	﹤0.01%	6783

Other funds holding STTK

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

CEI

Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Raymond James Financial's STTK Position: Q3 2025 in Review

Raymond James Financial sold out of Shattuck Labs (STTK) in Q3 2025, closing a stake of 250 shares — an estimated $198 sold.

Raymond James Financial first reported a position in STTK in Q2 2025 and held it in 1 quarter. The position peaked at $198 in Q2 2025. 56 funds tracked by Wall St. Rank hold STTK as of Q3 2025.

Raymond James Financial reported no remaining Shattuck Labs position as of Q3 2025 after selling out during the quarter.
Raymond James Financial sold 250 Shattuck Labs shares in Q3 2025, an estimated $198.
Raymond James Financial first reported a position in Shattuck Labs in Q2 2025 and held it in 1 quarter.
Raymond James Financial's Shattuck Labs position peaked at $198 in Q2 2025.
56 funds tracked by Wall St. Rank held Shattuck Labs as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.